• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清细胞因子水平及其与自身免疫性肝病患者临床特征的关系。

Serum Cytokine Levels and Their Relation to Clinical Features in Patients with Autoimmune Liver Diseases.

机构信息

Kazan State Medical University, Kazan, Russia.

Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.

出版信息

J Immunol Res. 2017;2017:9829436. doi: 10.1155/2017/9829436. Epub 2017 Feb 19.

DOI:10.1155/2017/9829436
PMID:28299346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5337382/
Abstract

Serum cytokine levels were explored in a combined group of patients with autoimmune liver diseases (AILDs) and separately in patients with autoimmune hepatitis (AIH) and overlap syndrome. Overall, 60 patients with AILD, among them 32 patients with AIH and 28 patients with overlap syndrome, were included in the cross-sectional study. Serum cytokine levels were measured at baseline and compared to those of 21 healthy controls. Patients with AILD had significantly higher levels of IL-6 (0.70 (range 0.17-99.86) in patients with AILD compared to 0.40 (range 0.14-2.65) in controls, < 0.01), IL-8 (1.66 (0.45-34.58) versus 0.53 (0.35-2.38), resp., < 0.01), and TNF- (2.61 (0.23-120.88) versus 1.65 (0.21-7.54), resp., < 0.01). Adjusted logistic regression analysis revealed a pronounced relation of IL-8 and AILD, 48.36 (3.63-643.60), as well as AIH, 18.54 (1.08-318.54), and overlap syndrome, 23.85 (2.37-240.23), while the associations between the level of other cytokines and AILD were assessed as nonsignificant. In the language of absolute numbers, the increase of IL-8 serum level by 1 pg/mL had increased the chance for a patient to find himself in a group of AILD by 48.36 times. Also, high IL-8 serum levels were strongly related to clinical parameters.

摘要

在自身免疫性肝病(AILD)患者的综合组中以及在自身免疫性肝炎(AIH)患者和重叠综合征患者中分别探讨了血清细胞因子水平。这项横断面研究共纳入 60 名 AILD 患者,其中 32 名 AIH 患者和 28 名重叠综合征患者。在基线时测量了血清细胞因子水平,并与 21 名健康对照者进行了比较。AILD 患者的 IL-6 水平明显升高(AILD 患者为 0.70(范围 0.17-99.86),而对照组为 0.40(范围 0.14-2.65),<0.01)、IL-8(1.66(0.45-34.58)比对照组 0.53(0.35-2.38),<0.01)和 TNF-(2.61(0.23-120.88)比对照组 1.65(0.21-7.54),<0.01)。调整后的逻辑回归分析显示,IL-8 与 AILD 显著相关,OR 为 48.36(3.63-643.60),与 AIH 也显著相关,OR 为 18.54(1.08-318.54),与重叠综合征也显著相关,OR 为 23.85(2.37-240.23),而其他细胞因子水平与 AILD 的相关性被评估为无统计学意义。从绝对值来看,IL-8 血清水平增加 1 pg/mL,患者患 AILD 的几率增加 48.36 倍。此外,高 IL-8 血清水平与临床参数密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90d/5337382/833c72891fec/JIR2017-9829436.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90d/5337382/833c72891fec/JIR2017-9829436.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90d/5337382/833c72891fec/JIR2017-9829436.001.jpg

相似文献

1
Serum Cytokine Levels and Their Relation to Clinical Features in Patients with Autoimmune Liver Diseases.血清细胞因子水平及其与自身免疫性肝病患者临床特征的关系。
J Immunol Res. 2017;2017:9829436. doi: 10.1155/2017/9829436. Epub 2017 Feb 19.
2
Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.口腔微生物失调及其与自身免疫性肝病唾液免疫生物学标志物的关系。
PLoS One. 2018 Jul 3;13(7):e0198757. doi: 10.1371/journal.pone.0198757. eCollection 2018.
3
Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.1型自身免疫性肝炎和原发性胆汁性肝硬化具有不同的骨髓细胞因子产生情况。
J Autoimmun. 2005 Dec;25(4):283-8. doi: 10.1016/j.jaut.2005.08.002. Epub 2005 Oct 20.
4
Elevated circulating levels of IL-21 and IL-22 define a cytokine signature profile in type 2 autoimmune hepatitis patients.2型自身免疫性肝炎患者循环中IL-21和IL-22水平升高,定义了一种细胞因子特征谱。
Ann Hepatol. 2016 Jul-Aug;15(4):550-8.
5
Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis.1型自身免疫性肝炎和原发性胆汁性肝硬化患者骨髓单个核细胞中细胞活化及凋亡标志物
J Hepatol. 2005 Mar;42(3):393-9. doi: 10.1016/j.jhep.2004.11.023.
6
Spectrum of autoimmune liver diseases in western India.印度西部自身免疫性肝病的谱系
J Gastroenterol Hepatol. 2007 Dec;22(12):2112-7. doi: 10.1111/j.1440-1746.2007.05048.x. Epub 2007 Jul 9.
7
Autoimmune liver diseases and antiphospholipid antibodies positivity: a meta-analysis of literature studies.自身免疫性肝病与抗磷脂抗体阳性:文献研究的荟萃分析
J Gastrointestin Liver Dis. 2015 Mar;24(1):25-34, 3 p following 34. doi: 10.15403/jgld.2014.1121.amb.
8
Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.酒精性肝炎患者的血浆内毒素和血清细胞因子水平:与肝脏损害严重程度的关系。
Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):48S-54S.
9
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases.系统性红斑狼疮患者的自身免疫性肝病:147例回顾性分析
Scand J Gastroenterol. 2011 Jun;46(6):732-7. doi: 10.3109/00365521.2011.558114. Epub 2011 Feb 25.
10
Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis.重叠综合征:自身免疫性肝炎合并原发性胆汁性肝硬化。
J Assoc Physicians India. 2010 Jul;58:455-6.

引用本文的文献

1
The Role of Novel Immunomodulators in the Treatment of Autoimmune Hepatitis.新型免疫调节剂在自身免疫性肝炎治疗中的作用
J Clin Transl Hepatol. 2025 Jun 28;13(6):493-503. doi: 10.14218/JCTH.2025.00008. Epub 2025 May 13.
2
Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome.多组学方法在原发性胆汁性胆管炎和自身免疫性肝炎变异综合征的药物反应特征中的应用。
J Transl Med. 2024 Feb 29;22(1):214. doi: 10.1186/s12967-024-05029-6.
3
β-arrestin2 deficiency ameliorates S-100-induced autoimmune hepatitis in mice by inhibiting infiltration of monocyte-derived macrophage and attenuating hepatocyte apoptosis.

本文引用的文献

1
Cirrhosis and autoimmune liver disease: Current understanding.肝硬化与自身免疫性肝病:当前认识
World J Hepatol. 2016 Oct 8;8(28):1157-1168. doi: 10.4254/wjh.v8.i28.1157.
2
Worldwide Incidence of Autoimmune Liver Disease.自身免疫性肝病的全球发病率。
Dig Dis. 2015;33 Suppl 2:2-12. doi: 10.1159/000440705. Epub 2015 Dec 7.
3
Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.肝硬化中的免疫功能障碍:根据肝硬化严重程度的不同细胞因子表型
β-arrestin2 缺乏通过抑制单核细胞来源的巨噬细胞浸润和减轻肝细胞凋亡来改善 S-100 诱导的小鼠自身免疫性肝炎。
Acta Pharmacol Sin. 2023 Oct;44(10):2048-2064. doi: 10.1038/s41401-023-01103-9. Epub 2023 May 25.
4
Immune-Related Multiple-Organs Injuries Following ICI Treatment With Tislelizumab in an Advanced Non-Small Cell Lung Cancer Patient: A Case Report.替雷利珠单抗免疫检查点抑制剂治疗晚期非小细胞肺癌患者后出现的免疫相关多器官损伤:一例报告
Front Oncol. 2021 Sep 2;11:664809. doi: 10.3389/fonc.2021.664809. eCollection 2021.
5
Compromise or not? A case report of successful treatment of pembrolizumab-induced hepatitis in a patient with non-small cell lung cancer with low-dose methylprednisolone and bicyclol.妥协还是不妥协?低剂量甲基强的松龙和双环醇成功治疗非小细胞肺癌患者因帕利珠单抗引起的肝炎 1 例报告。
Thorac Cancer. 2020 Jul;11(7):2023-2030. doi: 10.1111/1759-7714.13463. Epub 2020 May 7.
6
Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma-An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer.免疫激活与恶性黑色素瘤组织损伤的相关性监测——免疫检查点抑制剂治疗癌症过程中识别耐受崩溃的算法。
Int J Mol Sci. 2020 Mar 16;21(6):2020. doi: 10.3390/ijms21062020.
7
Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation.经典树突状细胞通过自噬调控在自身免疫性肝炎中的关键作用。
Cell Death Dis. 2020 Jan 13;11(1):23. doi: 10.1038/s41419-019-2217-6.
8
Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis.青少年自身免疫性肝炎的新型诊断与治疗策略
Front Pediatr. 2019 Sep 20;7:382. doi: 10.3389/fped.2019.00382. eCollection 2019.
9
Association of rs6000782 and rs1799724 variants with paediatric-onset autoimmune hepatitis.rs6000782和rs1799724基因变异与儿童期自身免疫性肝炎的关联
J Adv Res. 2018 Oct 20;15:103-110. doi: 10.1016/j.jare.2018.10.001. eCollection 2019 Jan.
10
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.抗肿瘤坏死因子-α(TNF-α)对肝脏的有害影响和潜在益处。
Int J Mol Sci. 2018 Jul 27;19(8):2199. doi: 10.3390/ijms19082199.
Cytokine. 2016 Jan;77:14-25. doi: 10.1016/j.cyto.2015.10.006. Epub 2015 Oct 23.
4
Cell mediators of autoimmune hepatitis and their therapeutic implications.自身免疫性肝炎的细胞介质及其治疗意义。
Dig Dis Sci. 2015 Jun;60(6):1528-42. doi: 10.1007/s10620-014-3473-z. Epub 2014 Dec 9.
5
Diagnosis and management of overlap syndromes.重叠综合征的诊断与管理
Clin Liver Dis. 2015 Feb;19(1):81-97. doi: 10.1016/j.cld.2014.09.005. Epub 2014 Nov 21.
6
Mechanisms of autoimmune liver disease.自身免疫性肝病的发病机制。
Discov Med. 2014 Nov;18(100):255-63.
7
Treatment of autoimmune liver disease: current and future therapeutic options.自身免疫性肝病的治疗:当前和未来的治疗选择。
Ther Adv Chronic Dis. 2013 May;4(3):119-41. doi: 10.1177/2040622313478646.
8
Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.白细胞介素-8 在慢性肝病患者中被激活,并与人类肝纤维化中肝巨噬细胞的积累有关。
PLoS One. 2011;6(6):e21381. doi: 10.1371/journal.pone.0021381. Epub 2011 Jun 22.
9
Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.白细胞介素-17 通过诱导肝脏白细胞介素-6 的表达促进自身免疫性肝炎的发病机制。
PLoS One. 2011 Apr 19;6(4):e18909. doi: 10.1371/journal.pone.0018909.
10
Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.重叠综合征:国际自身免疫性肝炎组织(IAIHG)关于一个有争议问题的立场声明。
J Hepatol. 2011 Feb;54(2):374-85. doi: 10.1016/j.jhep.2010.09.002. Epub 2010 Sep 18.